These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1706590)

  • 21. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.
    Smith AJ; Cho MI; Hammarskjöld ML; Rekosh D
    J Virol; 1990 Jun; 64(6):2743-50. PubMed ID: 1692347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
    Lee AH; Lee HY; Sung YC
    Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Arrigo SJ; Chen IS
    Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells.
    Chen J; Ido E; Jin M; Kuwata T; Igarashi T; Mizuno A; Koyanagi Y; Hayami M
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():741-5. PubMed ID: 9568969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
    Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
    AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Karacostas V; Nagashima K; Gonda MA; Moss B
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism.
    Stephens EB; Mukherjee S; Sahni M; Zhuge W; Raghavan R; Singh DK; Leung K; Atkinson B; Li Z; Joag SV; Liu ZQ; Narayan O
    Virology; 1997 May; 231(2):313-21. PubMed ID: 9168893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein.
    Ratner L; Vander Heyden N; Garcia J; Polinsky M; Westervelt P; Becich M
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):287-94. PubMed ID: 1829617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.
    Larder BA; Kemp SD; Purifoy DJ
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4803-7. PubMed ID: 2472634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus agm3 chimeric viruses in human and monkey cells: the 5' half of the HIV-1 genome is responsible for virus cytopathogenicity.
    Jin M; Ido E; Kuwata T; Igarashi T; Cichutek K; Kurth R; Miura T; Enose Y; Chen J; Hayami M
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2427-31. PubMed ID: 8887473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of human immunodeficiency virus type 1 integrase mutants.
    Ansari-Lari MA; Donehower LA; Gibbs RA
    Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
    Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
    Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.
    Luciw PA; Cheng-Mayer C; Levy JA
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1434-8. PubMed ID: 2434956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.